Provided by Tiger Trade Technology Pte. Ltd.

Lipocine

2.06
-0.0300-1.44%
Volume:26.73K
Turnover:55.62K
Market Cap:16.98M
PE:-1.13
High:2.10
Open:2.07
Low:2.05
Close:2.09
52wk High:12.37
52wk Low:1.81
Shares:8.24M
Float Shares:6.55M
Volume Ratio:0.97
T/O Rate:0.41%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.8181
EPS(LYR):-1.7669
ROE:-60.94%
ROA:-37.04%
PB:0.78
PE(LYR):-1.17

Loading ...

Lipocine posts Phase 3 LPCN 1154 postpartum depression trial presentation

Reuters
·
May 28

Lipocine Showcases Phase 3 Data in Postpartum Depression

TIPRANKS
·
May 27

Lipocine Phase 3 postpartum depression trial data for LPCN 1154 set for ASCP talk

Reuters
·
May 19

Lipocine Announces Lpcn 1154 Phase 3 Data Accepted for Oral Presentation at 2026 Ascp Annual Meeting

THOMSON REUTERS
·
May 19

Lipocine Showcases Pipeline at Virtual Healthcare Conference

TIPRANKS
·
May 18

Lipocine joins A.G.P. Annual Healthcare Company Showcase fireside chat

Reuters
·
May 18

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
May 11

CORRECTION: Lipocine Q1 EPS $(0.54) Misses $(0.48) Estimate, Sales $119.397K Miss $162.500K Estimate

Benzinga Earnings
·
May 08

BRIEF-Lipocine Q1 EPS USD -0.54

Reuters
·
May 08

Lipocine Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 07

Lipocine Q1 net loss widens to $3.7 million; royalty revenue rises to $119,000

Reuters
·
May 07

Lipocine Inc expected to post a loss of 48 cents a share - Earnings Preview

Reuters
·
May 04

BRIEF-Lipocine Inc Spyros Papapetropoulos Resigns As Board Member Effective April 16, 2026

Reuters
·
Apr 22

Lipocine announces annual shareholder meeting

Reuters
·
Apr 22

Lipocine names R. Dana Ono chairman after Papapetropoulos resigns from board

Reuters
·
Apr 22

Lipocine Inc - Spyros Papapetropoulos Resigns as Board Member Effective April 16, 2026 - SEC Filing

THOMSON REUTERS
·
Apr 22

Lipocine price target lowered to $6 from $11 at Alliance Global

TIPRANKS
·
Apr 14

Top Lipocine Insiders Make Bold Move With Fresh Share Purchases

TIPRANKS
·
Apr 07

Lipocine director John W. Higuchi buys $252,150 common shares

Reuters
·
Apr 07

Lipocine CEO Mahesh Patel acquires $50,750 common shares

Reuters
·
Apr 07